23
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Secretory vesicle analysis for discovery of low abundance plasma biomarkers

, PhD & , PhD
Pages 475-485 | Published online: 29 Apr 2008

Bibliography

  • Das RC. Proteins and antibodies make advances as therapeutic products. Am Clin Lab 2001;8:10-4
  • Bonin-Debs AL, Boche I, Gille H, Brinkman U. Development of secreted proteins as biotherapeutic agents. Expert Opin Biol Ther 2004;4:551-8
  • Schatz G, Dobberstein B. Common principles of protein translocation across membranes. Science 1996;271:1519-26
  • Lee MC, Miller EA, Goldberg J, et al. Bi-directional protein transport between the ER and Golgi. Annu Rev Cell Dev Biol 2004;20:87-123
  • Keller P, Simons K. Post-Golgi biosynthetic trafficking. J Cell Sci 1997;110: 3001-9
  • Palade G. Intracellular aspects of the process of protein synthesis. Science 1975;189:347-58
  • Clark HF, Gurney AL, Abaya E, et al. The secreted protein discovery initiative (SPDI) a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res 2003;13:2265-70
  • Arnoys EJ, Wang JL. Dual localization: proteins in extracellular and intracellular compartments. Acta histochemica 2007;109:89-110
  • Fevrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004;16:415-21
  • Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen presentation vesicles. J Exp Med 1996;183:1161-72
  • Wubbolts R, Leckie RS, Veenhuizen PT, et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 2003;278:10963-72
  • Keller S, Sanderson MP, Stoeck A, Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol Lett 2006;107:102-8
  • van Niel G, Porto-Carreiro I, Simoes S, Raposo G. Exosomes: a common pathway for a specialized function. J Biochem 2006;140:13-21
  • Chaput N, Flament C, Viaud S, et al. Dendritic cell derived-exosomes: biology and clinical implementations. J Leuk Biol 2006;80:471-8
  • Fukuda M, Kanno E, Ogata Y, et al. Nerve growth factor-dependent sorting of Synaptotagmin IV protein into mature dense-core vesicles that undergo calcium dependent exocytosis in PC12 cells. J Biol Chem 2003;278:3220-6
  • Potolicchio I, Carven GJ, Xu X, et al. Proteomic analysis of microglia-derived exosomes: metabolic role of the Aminopeptidase CD13 in neuropeptide catabolism. J Immunol 2005;175:2237-43
  • Stein JM and Luzio JP. Ectocytosis caused by sublytic autologous complement attack on human neutrophils. Biochem J 1991;274:381-6
  • Slavkin HC, Croissant RD, Bringras P, et al. Matrix vesicle heterogeneity: possible morphogenetic functions for matrix vesicles. Fed Proc 1976;35:127-34
  • Nickel W. The mystery of non-classical protein secetion. A current view on cargo proteins and potential export routes. Eur J Biochem 2003;270:2109-19
  • Joliot A, Maizel A, Rosenberg D, et al. Identification of a signal sequence necessary for the unconventional secretion of an engrailed homeprotein. Curr Biol 1998;8:856-63
  • SPD: Secreted Protein Database. Available from: http://spd.cbi.pku.edu.cn/
  • Polanski M, Anderson NL. A list of candidate cancer biomarkers for targeted proteomics. Biomarker Insights 2006;2:1-48
  • Ma Y, Visser L, Roelofsen H, et al. Proteomics analysis of Hodgkin lymphoma: Identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. Blood 2007: published online 10 December 2007, doi:10.1182/blood-2007-09-112128
  • Kulasingam V, Diamandis EP. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol Cell Proteomics 2007;6:1997-2011
  • Martin DB, Gifford DR, Wright ME, et al. Quantitative proteomic analysis of proteins released by neoplastic prostate epithelia. Cancer Res 2004;64:347-55
  • Moscova M, Marsh DJ, Baxter RC. Protein chip discovery of secreted proteins regulated by the phosphotidylinositol 3-kinase pathway in ovarian cancer cell lines. Cancer Res 2006;66:1376-83
  • Mbeunkui F, Metge BJ, Shevde LA, Pannell LK. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. J Prot Res 2007;6:2993-3002
  • Gronborg M, Kristiansen TZ, Iwahori A, et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 2006;5:157-71
  • Yang G, Truong LD, Timme TL, et al. Elevated expression of calveolin is associated with prostate and breast cancer. Clin Cancer Res 1998;4:1873-80
  • Tahir SA, Ren C, Timme TL, et al. Development of an Immunoassay for serum calveolin-1: A novel biomarker for prostate cancer. Clin Cancer Res 2003;9:3653-9
  • Jessani N, Liu Y, Humphrey M, Cravatt BF. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc Natl Acad Sci USA 2002;99:10335-40
  • van den Bemd GJ, Krijgsveld J, Luide TM, et al. Mass spectrometric identification of human prostate cancer-derived proteins in serum of xenograft-bearing mice. Mol Cell Proteomics 2006;5:1830-9
  • Whiteaker JR, Zhang H, Zhao L, et al. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. 2007;6:3962-75
  • Huang C-M, Ananthaswamy HN, Barnes S, et al. Mass spectrometric proteomics profiles of in vivo tumor secretomes: Capillary ultrafiltration sampling of regressive tumor masses. Proteomics 2006;6:6107-16
  • Shi Y, Elmets CA, Smith JW, et al. Quantitative proteomes and in vivo secretomes of progressive and regressive UV-induced fibrosarcoma tumor cells: Mimicking tumor microenvornment using a dermis-based cell-trapped system linked to tissue chamber. Proteomics 2007;7:4589-600
  • Mor G, Visintin I, Lai Y, et al. Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci USA 2005;102:7677-82
  • Maurya P, Meleady P, Dowling P, Clynes M. Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res 2007;27:1247-56
  • Roessler M, Rollinger W, Mantovani-End L, et al. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol Cell Proteomics 2006;5:2092-102
  • Bjartell A, Johansson R, Bjork T, et al. Immunohistochemical detection of Cysteine-rich secretory protein 3 in tissues and in serum from men with cancer or benign enlargement of the prostate gland. Prostate 2006;66:591-603
  • Hale PH, Price DT, Sanchez LM, et al. Zinc α-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancer. Clin Cancer Res 2001;7:846-53
  • Celis JE, Gromov P, Cabezon T, et al. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment. Mol Cell Proteomics 2004;3:327-44
  • Bard MP, Hegmans JP, Hemmes A, et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol 2004;31:114-21
  • Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 2007;6:25-38
  • Matharoo-Ball B, Ball G, Rees R. Clinical proteomics: Discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches – a prostate cancer perspective. Vaccine 2007;25S:B110-21
  • Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotech 2006;24:971-83
  • Roy CR, Tilney LG. The road less traveled: transport of Legionella to the endoplasmic reticulum. J Cell Biol 2002;158:415-9
  • Belland RJ, Zhong G, Crane DD, et al. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci USA 2003;100:8478-83
  • Hayward RD, Hume PJ, McGhie EJ, Koronakis V. A Salmonella SipB-derived polypeptide blocks the ‘trigger’ mechanism of bacterial entry into eukaryotic cells. Mol Microbiol 2002;45:1715-27
  • Mota LJ, Cornelis GR. The bacterial injection kit: type III secretion systems. Ann Med 2005;37:234-49
  • Meghari S, Desnues B, Capo C, et al. Coxiella burnetii stimulates production of RANTES and MCP-1 by mononuclear cells: modulation by adhesion to endothelial cells and its implications in Q fever. Eur Cytokine Netw 2006;17:253-9
  • Samuel LP, Song CH, Wei J, et al. Expression, production and release of the Eis protein by Mycobacterium tuberculosis during infection of macrophages and its effect on cytokine secretion. Microbiology 2007;153:529-40
  • Bodet C, Chandad F, Grenier D. Modulation of cytokine production by Porphyromonas gingivalis in a macrophage and epithelial cell-co-culture model. Microbes Infect 2005;7:448-56
  • Marie JC, Saltel F, Escola JM, et al. Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression. J Virol 2004; 78:11952-61
  • Gounaris K. Nucleotide cascades are catalyzed by secreted proteins of the parasitic nematode Trichinella spiralis. Infect Immun 2002;70:4917-24
  • Derre I, Isberg RR. LidA, a translocated substrate of the Legionella pneumophila Type IV secretion system, interferes with the early secretory pathway. Infect Immun 2005;73:4370-80
  • Hess J, Gentschev I, Miko D, et al. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci USA 1996;93:1458-63
  • Daugelat S, Ladel CH, Schoel B, Kaufmann SHE. Antigen-specific T-cell responses during primary and secondary Listeria monocytogenes infection. Infect Immun 1994;62:1881-8
  • Bahk YY, Kim SA, Kim JS, et al. Antigens secreted from Mycobacterium tuberculosis: identification by proteomics approach and test for diagnostic biomarker. Proteomics 2004;4:3299-307
  • Achkar JM, Dong Y, Holzman RS, et al. Mycobacterium tuberculosis Malate Synthase- and MPT51 Based Serodiagnostic Assay as an Adjunct to Rapid Identification of Pulmonary Tuberculosis. Clin Vaccine Immunol 2006;13:1291-3
  • Brakenhielm E, Cao R, Gao B, et al. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 2004;94:1579-88
  • Rupnick MA, Panigraphy D, Zhang C-Y, et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 2002;99:10730-5
  • Kolonin MG, Saha PK, Chan L, et al. Reversal of obesity by targeted ablation of adipose tissue. Nat Med 2004;10:625-32
  • Mehta S, Farmer JA. Obesity and inflammation: A new look at an old problem. Curr. Atheroscler. Rep 2007;9:134-8
  • Lago F, Dieguez C, Gomez-Reino J, Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 2007;3:716-24
  • Iannucci CV, Capoccia D, Calabria M, Leonetti F. Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targets. Curr Pharm Des 2007;13:2148-68
  • Yang R, Barouch LA. Leptin signaling and obesity: Cardiovascular consequences. Circ Res 2007;101:545-59
  • Malendowicz LK, Rucinski M, Belloni AS, et al. Leptin and the regulation of the hypothalamic-pitiuitary-adrenal axis. Int Rev Cytol 2007;263:63-102
  • Wilkinson M, Brown R, Imran SA, Ur E. Adipokine gene expression in brain and pituitary gland. Neuroendocrinology 2007;86:191-209
  • Louis GW, Myers MG. The role of leptin in the regulation of neuroendocrine function and CNS development. Rev Endocr Metab Disord 2007;8:85-94
  • Oller do Nascimento C, Hunter L, Trayhurn P. Regulation of haptoglobin gene expression in 3T3-L1 adipocytes by cytokines, catecholamines, and PPARγ. Biochem Biophys Res Comm 2004;313:702-8
  • Voros G, Maquoi E, Demeulemeester D, et al. Modulation of Angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 2005;146:4545-54
  • Tsuruga H, Kumagai H, Kojima T, Kitamura T. Identification of novel membrane and secreted proteins upregulated during adipocyte differentiation. Biochem Biophys Res Comm 2000;272:293-7
  • Kratchmarova I, Kalume DE, Blagoev B, et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002;1:213-22
  • Xu A, Wang Y, Xu JY, et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006;52:405-13
  • Welsh GI, Griffiths MR, Webster KJ, et al. Proteome analysis of adipogenesis. Proteomics 2004;4:1042-51
  • Alvarez-Llamas G, Szalowska E, de Vries MP, et al. Characterization of the human visceral adipose tissue secretome. Mol Cell Proteomics 2007;6:589-600
  • Chen X, Cushman SW, Pannell LK, Hess S. Quantitative proteomic analysis of the secretory proteins from rat adipose cells using 2D liquid chromatography-MS/MS approach. J Proteome Res 2005;4:570-7
  • Grimsrud PA, Picklo MJ, Griffin TJ, Bernlohr DA. Carbonylation of adipose proteins in obesity and insulin resistance. Mol Cell Proteomics 2007;6:624-37
  • Celis JE, Moreira JMA, Cabezon T, et al. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients. Mol Cell Proteomics 2005;4:492-522
  • Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002;296:1046-9
  • Hansen RK, Bissell MJ. Tissue architecture and breast cancer: The role of extracellular matrix and steroid hormones. Endocr Relat Cancer 2000;7:95-113
  • Burtis CA, Ashwood ER, Bruns DE, editors. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. St. Louis: Elsevier Saunders Co.; 2006
  • Fu Q, Van Eyk JE. Proteomics and heart disease: identifying biomarkers of clinical utility. Expert Rev Proteomics 2006;3:237-49
  • Sonnen JA, Keene CD, Montine KS, et al. Biomarkers for Alzheimer's disease. Expert Rev Neurother 2007;7:1021-8
  • Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-67
  • Thadikkaran LM, Siegenthaler MA, Crettaz D, et al. Recent advances in blood-related proteomics. Proteomics 2005;5:3019-34
  • Oprins A, Rabouille C, Posthuma G, et al. The ER to Golgi interface is the major concentration site of secretory proteins in the exocrine pancreatic cell. Traffic 2001;2:831-8
  • Lanoix J, Ouwendijk J, Lin CC, et al. GTP hydrolysis by arf-1 mediates sorting and concentration of Golgi resident enzymes into functional COP I vesicles: EMBO J 1999;18:4935-48
  • Lanoix J, Ouwendijk J, Stark A, et al. Sorting of Golgi resident proteins into different subpopulations of COPI vesicles: a role for ArfGAP1. J Cell Biol 2001;155:1199-212
  • Sircar K, Gaboury L, Ouadi L, et al. Isolation of human prostatic epithelial plasma membranes for proteomics using mirror image tissue banking of radical prostatectomy specimens. Clin Cancer Res 2006;12:4178-84
  • Fujiki Y, Hubbard AL, Fowler S, Lazarow PB. Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J Cell Biol 1982;93:97-102
  • Lamontagne J, Butler H, Chaves-Olarte E, et al. Extensive cell envelope modulation is associated with virulence in Brucella abortus. J Proteome Res 2007;6:1519-29
  • Ohkawara T, Nishihira J, Takeda H, et al. Pathophysiological roles of macrophage migration inhibitory factor in gastrointestinal, hepatic, and pancreatic disorders. J Gastroenterol 2005;40:117-22
  • Meyer-Siegler KL, Bellino MA, Tannenbaum M. Macrophage migration inhibitory actor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma. Cancer 2002;94:1449-56
  • Gewin V. Missing the mark. Nature 2007;449:770-1
  • Clark CM, Xie S, Chittans J, et al. Cerebrospinal fluid Tau and β-amyloid. How well do these markers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 2003;60:1696-702
  • Hampel H, Teipel SJ, Padberg F, et al. Discriminant power of combined cerebrospinal fluid t protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease. Brain Res 1999;823:104-12
  • Alaoui-Jamali MA, Xu Y-J. Proteomic technology for biomarker profiling in cancer: an update. J Zheijiang U Science B 2006;7:411-20
  • The Federal Drug Administration website Available from: www.fda.org

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.